News

CAR T-Cell therapy is being explored in multiple approaches to treat hematologic malignancies.

The clinical benefits and safety profiles for ribociclib remained consistent when treating both younger and elderly patients with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer.

Neuroendocrine tumors (NETs) are rare and often misdiagnosed. These tips can help with the diagnosing and treatment of patients with NETs, and carcinoid syndrome.

World Cancer Day encourages people internationally to raise awareness about cancer prevention and early detection, such as through "Support through Sport."

Oral adherence is a growing problem for patients with breast cancer.

The American Society of Clinical Oncology named Immunotherapy 2.0 as the Advance of the Year, as it continues to move the cancer field forward.

The FDA has granted approval for nivolumab (Opdivo) in the treatment of urothelial carcinoma.

Rosemary Ford, BSN, RN looks back on her nursing career, including her time spent in the early years of the Bone Marrow Transplant program led by Nobel Prize winner Donnall Thomas, MD.

Genitourinary cancer expert discusses autoimmune-related adverse events in patients with renal cell carcinoma (RCC).

After the presidential executive order limiting immigration on Friday, several oncology organizations responded with statements expressing concern.

Cancer-related post-traumatic stress disorder (PTSD) could affect as many as 30% to 60% of patients with cancer.

Steve Pake of Testicular Cancer Awareness Foundation offers insight about follow-up care for patients after testicular cancer.

Nurses and pharmacists offer 7 quick tips for oral adherence in patients with cancer.

Tips from the National Leiomyosarcoma Foundation for making the most of your appointments and care.

Gynecologic oncology and reproductive medicine expert discusses the new HPV vaccine recommendations and the importance of awareness for all HPV-caused cancers.

A dynamic and uplifting evening of live music hosted by WBZ’s Jordan Rich to strike a chord and raise awareness of the changing face of lung cancer.

NFL Hall of Famer Jim Kelly discusses how cancer touched his family with his diagnosis of head and neck cancer, and his involvement in Your Cancer Game Plan.

An upcoming study hopes to expand the use of tumor treating fields (TTFields) from only glioblastoma (grade IV tumors) into also treating grade III anaplastic astrocytomas as well.

Patients in a small study who were placed on a certain diet plan for three months saw a decrease in fatigue from breast cancer treatments.

A recent study found that a significant number of patients with advanced lung cancer were not receiving potentially beneficial treatment.

Tips to stay healthy this winter from Genny's Hope Foundation

A recent study sought to evaluate clinician expectations of benefits and harms of treatments, imaging, and screening.

Denise Yardley discusses the tnAcity study for patients with metastatic triple-negative breast cancer (TNBC), and nab-paclitaxel.

The antidiabetic agent, pioglitazone, may possibly increase the risk of bladder cancer, according to the FDA.

A recent study evaluated the relationship between polycystic ovarian syndrome (PCOS), long or irregular periods, and ovarian cancer risk.

For patients with rectal cancer, the "watch-and-wait" approach of avoiding surgery after induction therapy is emerging as a treatment option.

The FDA has granted accelerated approval of ibrutinib for treatment of marginal zone lymphona (MZL).

TESARO, manufacturer of the PARP inhibitor niraparib has opened an expaned access program (EAP) for women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer after complete or partial response to platinum-based chemotherapy.

As the Affordable Care Act (ACA, or Obamacare) seems to hang in the balance, medical organizations, advocacy groups and patients speak out on what they hope to see in the future of healthcare.

Patients with esophogeal cancers who received induction chemotherapy, followed by PET imaging to determine whether alternative chemotherapy was needed had improved pathologic complete response rates